These properties of fetuin-A have a high translational potential in human medicine, as it is not restricted to the treatment of hypoxia/ischemia-related injury, but could also be applicable as a replacement therapy in conditions associated with fetuin-A depletion such as CKD or acute inflammation. This evidence concerns the gene AHSG and chronic kidney disease.